Qiagen to Bundle Reagents With ActiveSight s CrystalScan for Protein-crystallization Offering
Feb 22, 2006
NEW YORK, Feb. 22 (GenomeWeb News) - Qiagen will bundle its sample preparation consumables with ActiveSight's CrystalScan protein-crystallization screening service, the companies said today.
Financial terms of the agreement were not disclosed.
Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.
Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.